|View printer-friendly version|
|Gevo Receives Key Patent from USPTO for Efficient Production of Isobutanol|
~ Further Grows Strong Patent Estate ~
Englewood, CO— December 6, 2011—Gevo, Inc. (NASDAQ: GEVO), a renewable chemicals and advanced biofuels company, today received a patent from the United States Patent and Trademark Office (“USPTO”) on another aspect of its yeast technology that enables the low-cost, high-yield production of biobased isobutanol.
Gevo was awarded U.S. Patent No. 8,071,358, covering additional “Methods of Increasing Dihydroxy Acid Dehydratase (DHAD) Activity to Improve Production of Fuels, Chemicals, and Amino Acids.”
“This invention further details and protects the innovations contained in the Gevo yeast organism to turn an industrial yeast strain into a highly efficient cell factory to produce isobutanol,” said Brett Lund, EVP & General Counsel of Gevo. “We continue to expect the breadth and strength of our patent estate to grow considerably over the coming months as our patent applications convert into issued patents.”
Although the company believes that the expectations reflected in these forward-looking statements are reasonable, these statements involve many risks and uncertainties that may cause actual results to differ materially from what may be expressed or implied in these forward-looking statements. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Gevo in general, see the risk disclosures in the Annual Report on Form 10-K of Gevo for the year ended December 31, 2010, and in subsequent reports on Forms 10-Q and 8-K and other filings made with the SEC by Gevo.